CD34+ Hematopoietic Stem and Progenitor Cell (HSPC) Gene Modification and Overnight Recovery (Day 0)
6:33
Cell Harvest and Infusion Preparation (Day 1)
7:42
Liquid Culture Quality Control (Days 1-5)
9:19
Results: Representative HSPC Identification and Analysis
10:34
Conclusion
文字起こし
To evaluate the efficiency and safety of promising and novel gene therapy approaches, the comprehensive testing of gene-modified cells in validated preclinical in vivo models is crucial. The conservation of relevant cell surface markers'cross-reac
このコンテンツにアクセスするにはサインインするか無料トライアルを開始してください
The goal of this protocol is to isolate nonhuman primate CD34+ cells from primed bone marrow, to gene-modify these cells with lentiviral vectors, and to prepare a product for infusion into the autologous host. The total protocol length is approximately 48 h.